Keith Baker, MD
Executive Medical Director, Gyroscope Therapeutics
Keith Baker is the Executive Medical Director for Gyroscope Therapeutics, Ltd. With over 20 years of clinical and industry experience in ophthalmology, Keith has worked in the life sciences industry since 2010 as a strategy consultant and Medical Affairs professional with IMS Consulting Group (now IQVIA), Regeneron, and Gyroscope. In that capacity, he has focused on identifying and addressing unmet clinical needs in ophthalmology and has developed extensive experience in market assessment, clinical trial design and execution, and communication of relevant data to a wide variety of stakeholders. Keith has co-authored numerous peer-reviewed publications and presentations addressing the treatment of retinal disease. Additionally, Keith has served as a consultant to multiple life science start-ups and venture investors. Keith is a graduate of Duke University, Dartmouth (Geisel) Medical School, and the Amos Tuck School of Business at Dartmouth College. He completed his ophthalmology residency training at the University of North Carolina Hospitals in Chapel Hill, NC, where he also served as Chief Resident. Over the course of his career, Keith has participated in ophthalmology mission trips to China, El Salvador, and rural Appalachia.